Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS study.

Baldomero EB, Ubago JG, Cercós CL, Ruiloba JV, Calvo CG, López RP.

Depress Anxiety. 2005;22(2):68-76.

PMID:
16094658
2.

[Effectiveness of venlafaxine extended release and conventional antidepressants in elderly patients with depressive disorder].

Agüera-Ortiz L, Ramos Garcia I.

Actas Esp Psiquiatr. 2006 May-Jun;34(3):153-61. Spanish.

PMID:
16736388
3.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
5.

Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.

Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA; OPERATION Study Team.

J Clin Psychopharmacol. 2010 Aug;30(4):357-64. doi: 10.1097/JCP.0b013e3181e7784f.

PMID:
20571433
6.

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M; STAR*D Study Team.

N Engl J Med. 2006 Mar 23;354(12):1231-42.

7.

Depression in primary care: effectiveness of venlafaxine extended-release in elderly patients; Observational study.

Cervera-Enguix S, Baca-Baldomero E, Garcia-Calvo C, Prieto-López R; TESEO Study Group.

Arch Gerontol Geriatr. 2004 May-Jun;38(3):271-80.

PMID:
15066313
8.

Effectiveness and safety of venlafaxine extended release in elderly depressed patients.

Ibor JJ, Carrasco JL, Prieto R, García-Calvo C; Ceres Study Group.

Arch Gerontol Geriatr. 2008 May-Jun;46(3):317-26. Epub 2007 Jul 6.

PMID:
17617478
9.

Venlafaxine extended-release in patients older than 80 years with depressive syndrome.

Baca E, Roca M, Garcia-Calvo C, Prieto R.

Int J Geriatr Psychiatry. 2006 Apr;21(4):337-43.

PMID:
16570327
10.

[Response and remission in depressive patients with anxiety symptoms treated with venlafaxine extended release in primary care].

Roca Benassar M, Baca Baldomero E.

Actas Esp Psiquiatr. 2006 May-Jun;34(3):162-8. Spanish.

PMID:
16736389
11.

Venlafaxine XR demonstrates higher rates of sustained remission compared to fluoxetine, paroxetine or placebo.

Shelton C, Entsuah R, Padmanabhan SK, Vinall PE.

Int Clin Psychopharmacol. 2005 Jul;20(4):233-8.

PMID:
15933485
13.

Mirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorder.

Benkert O, Szegedi A, Philipp M, Kohnen R, Heinrich C, Heukels A, van der Vegte-Senden M, Baker RA, Simmons JH, Schutte AJ.

J Clin Psychopharmacol. 2006 Feb;26(1):75-8.

PMID:
16415711
14.

Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.

Malhi GS, Ng F, Berk M.

Aust N Z J Psychiatry. 2008 Apr;42(4):346-9. doi: 10.1080/00048670701881587.

PMID:
18330778
15.

[Gender differences in clinical profile, response and remission of depressive patients treated with venlafaxine extended release].

Roca M, Baca E, Prieto R, García-Calvo C.

Actas Esp Psiquiatr. 2008 Mar-Apr;36(2):82-9. Spanish.

16.
17.

The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.

Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen RD, Yan B, Ahmed S, Musgnung J, Ninan PT.

J Clin Psychiatry. 2007 Aug;68(8):1246-56.

PMID:
17854250
18.

Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.

Trivedi MH, Wan GJ, Mallick R, Chen J, Casciano R, Geissler EC, Panish JM.

J Clin Psychopharmacol. 2004 Oct;24(5):497-506.

PMID:
15349005
19.
20.

A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.

Mazeh D, Shahal B, Aviv A, Zemishlani H, Barak Y.

Int Clin Psychopharmacol. 2007 Nov;22(6):371-5.

PMID:
17917556

Supplemental Content

Support Center